InspireMD Inc. (NSPR)
2.67
0.02 (0.75%)
At close: Jan 14, 2025, 3:55 PM
2.44
-8.61%
After-hours Jan 14, 2025, 05:39 PM EST
undefined% (undefined)
| Bid | 2 |
| Market Cap | 69.64M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -0.71 |
| PE Ratio (ttm) | -3.76 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 2.8 |
| Volume | 18,350 |
| Avg. Volume (20D) | 48,186 |
| Open | 2.65 |
| Previous Close | 2.65 |
| Day's Range | 2.56 - 2.74 |
| 52-Week Range | 1.81 - 3.42 |
| Beta | undefined |
About NSPR
InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system for use in carotid artery applications; and MGuard Prime embolic protection systems for use in patients with acute coronary syndromes, ...
Industry Medical - Devices
Sector Healthcare
IPO Date Apr 12, 2011
Employees 65
Stock Exchange NASDAQ
Ticker Symbol NSPR
Website https://www.inspiremd.com
Analyst Forecast
According to 2 analyst ratings, the average rating for NSPR stock is "Buy." The 12-month stock price forecast is $4.75, which is an increase of 77.90% from the latest price.
Buy 100.00%
Hold 0.00%
Sell 0.00%
Next Earnings Release
InspireMD Inc. is scheduled to release its earnings on Mar 5, 2025,
before market opens.
Analysts project revenue of $1.82M, reflecting a 3.35% YoY growth and earnings per share of -0.19, making a 18.75% increase YoY.
Analysts project revenue of $1.82M, reflecting a 3.35% YoY growth and earnings per share of -0.19, making a 18.75% increase YoY.
2 months ago ·
Source
+5.46%
InspireMD shares are trading higher after the comp...
Unlock content with
Pro Subscription
